Incremental value of retrospective SPECT CT software fusion imaging for neuroendocrine tumors.
Teaching Case Visit Teaching Case
Case presentaion:
- Male.
- 50 y.o.
- Diagnosed with a non hormone-producing, well-differentiated neuroendocrine tumor of the small intestine. A wide resection of the small intestine was practiced. Intraoperative examination of the gut did not disclose any other tumors in the intestinal mucosa. The patient recovered well and remained asymptomatic.
- One year after the surgery his cancer surgeon ordered an abdomial CT scan that was inhterpreted as unremarkable.
- Three months later he was also examined by this cancer endocrinologists whom in turn also decide to order a somatosin receptor scintigraphy.
Teaching points:
- SPECT should be a customary practice in cancer centers, either when using cancer tracer (e.g., In-111 or Tc-99m octreotide, I-131 sodium iodide, I-131 MIBG, Ga-67 citrate, Tc-99m(V) DMSA, Tc-99m MIBI) or not (e.g., Tc-99m MDP).
- In recognition of the incremental value of image fusion, Nuclear Medicne technologists should always consider the potential medical necessity to retrospectively fuse non-concurrently obtained SPECT and CT or MR images.
- Nuclear Medicine technologists should always follow a rigorous protocol to facilitate future image coregistration, including careful and reproducible patien positioning and using (radio-opaque and radioactive) external markers in a routinely fashion for every SPECT acquisition.